Factors such as the rising prevalence of cancer in many regions, rising awareness towards cancer diagnosis and treatment, introduction of novel pipeline drugs and therapies are expected to have a positive impact on the growth of global anticancer drugs market.
Albany, NY -- (SBWIRE) -- 03/19/2018 -- The global anticancer drugs market was valued at nearly US$ 85 billion in 2016, and it is projected that demand will grow at a steady pace during the assessment period 2017-2025. A research report titled "Anticancer Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025" has been added to the repository of Market Research Reports Search Engine (MRRSE) that offers holistic analysis and insights on the global anticancer drugs market.
Request for Sample Copy of Anticancer drugs Market Report @ https://www.mrrse.com/sample/4275
The report is a valuable source of insights and analysis and gives readers holistic information on the key factors influencing demand for anticancer drugs during the assessment period. The key growth factors, along with the restraining factors in the market have been analyzed. A thorough assessment on the opportunities and challenges in the market has been offered to readers.
According to the report, rising prevalence of cancer is one of the key factors that has necessitated the demand for anticancer drugs. These drugs are often used in conjunction with chemotherapy and radiation therapy. Increasing emphasis on cancer treatment, combined with growing healthcare investments in developing countries are likely to augment demand for anticancer drugs during the assessment period.
By drug type, the market has been segmented into cytotoxic, hormonal, and targeted. Among these, demand for targeted drugs continues to remains higher on account of its low side effects and growing use in targeted therapies. The targeted drug type segment is estimated to account for over 40% revenue share of the market.
By therapy type, the key segments include immunotherapy, targeted therapy, and chemotherapy. Among these, demand for anticancer drugs is highest in the targeted therapy segment. The targeted therapy segment is likely to grow at a CAGR of over 6% during the assessment period. By cancer type, demand for cancer drugs is likely to be highest in lung cancer segment. This segment is projected to grow at over 6% CAGR during the assessment period.
Read Detailed Index of full Research Study at: https://www.mrrse.com/anticancer-drugs-market
The report also offers a detailed region-wise analysis that offers readers information on the lucrative and sluggish markets globally. According to the report, North America and Europe continue to be lucrative markets, with Western Europe and the US among the most prominent regions. Demand for these drugs is steadily growing in Asia Pacific, where China, India, Japan, and Australia are among the key regions.
The report also includes a detailed competitive landscape section that profiles the strategies of leading players in the market. The product and business strategies of key players has been discussed in detail. Some of the leading players in the market include Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Pfizer Inc, Novartis AG, CELGENE CORPORATION, Amgen Inc, Bayer AG, AstraZeneca, Takeda Pharmaceutical Company Limited, and Merck & Co., Inc.
Do You Have Any Query or Specific Requirement? Ask to Our Industry Expert @
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE's repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY - 12207